Pilocytic Astrocytoma — Trials

Pilocytic Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01089101	Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma	active not recruiting	Phase 1 / Phase 2	217	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials
NCT01837862	A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas	active not recruiting	Phase 1 / Phase 2	10	Julie KrystalOTHER	1	Aug 6, 2026	clinicaltrials
NCT04985604	Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors	terminated	Phase 2	23	Day One Biopharmaceuticals, Inc.INDUSTRY	7	Oct 2, 2025	clinicaltrials
NCT01553149	Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

Data updated 4 days agoSource updated Sep 21, 2026source: clinicaltrials